Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records
25
Zitationen
30
Autoren
2024
Jahr
Abstract
PURPOSE: Current approaches to accurately identify immune-related adverse events (irAEs) in large retrospective studies are limited. Large language models (LLMs) offer a potential solution to this challenge, given their high performance in natural language comprehension tasks. Therefore, we investigated the use of an LLM to identify irAEs among hospitalized patients, comparing its performance with manual adjudication and International Classification of Disease (ICD) codes. METHODS: Hospital admissions of patients receiving immune checkpoint inhibitor (ICI) therapy at a single institution from February 5, 2011, to September 5, 2023, were individually reviewed and adjudicated for the presence of irAEs. ICD codes and an LLM with retrieval-augmented generation were applied to detect frequent irAEs (ICI-induced colitis, hepatitis, and pneumonitis) and the most fatal irAE (ICI-myocarditis) from electronic health records. The performance between ICD codes and LLM was compared via sensitivity and specificity with an α = .05, relative to the gold standard of manual adjudication. External validation was performed using a data set of hospital admissions from June 1, 2018, to May 31, 2019, from a second institution. RESULTS: 92.4%). The LLM spent an average of 9.53 seconds/chart in comparison with an estimated 15 minutes for adjudication. In the validation cohort (N = 1,270), the mean LLM sensitivity and specificity were 98.1% and 95.7%, respectively. CONCLUSION: LLMs are a useful tool for the detection of irAEs, outperforming ICD codes in sensitivity and adjudication in efficiency.
Ähnliche Arbeiten
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 · 30.917 Zit.
AJCC Cancer Staging Manual
2016 · 17.409 Zit.
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 · 15.284 Zit.
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
2010 · 15.084 Zit.
The blockade of immune checkpoints in cancer immunotherapy
2012 · 13.635 Zit.
Autoren
- Virginia H. Sun
- Julius C. Heemelaar
- Ibrahim Hadžić
- Vineet K. Raghu
- Chia‐Yun Wu
- Leyre Zubiri
- Azin Ghamari
- Nicole R. LeBoeuf
- Osama Abu-Shawer
- Kenneth L. Kehl
- Shilpa Grover
- Prabhsimranjot Singh
- Giselle Alexandra Suero‐Abreu
- Jessica Y. Wu
- Ayo Falade
- Kelley Grealish
- Molly Thomas
- Nora Hathaway
- Benjamin D. Medoff
- Hannah Gilman
- Alexandra–Chloé Villani
- Jor Sam Ho
- Meghan J. Mooradian
- Meghan E. Sise
- Daniel A. Zlotoff
- Steven M. Blum
- Michael Dougan
- Ryan J. Sullivan
- Tomas G. Neilan
- Kerry L. Reynolds
Institutionen
- Harvard University(US)
- Massachusetts General Hospital(US)
- Leiden University Medical Center(NL)
- Brigham and Women's Hospital(US)
- Intel (United States)(US)
- Maastricht University(NL)
- Mass General Brigham(US)
- Far Eastern Memorial Hospital(TW)
- Dana-Farber Cancer Institute(US)
- Cleveland Clinic(US)
- Salem Hospital(US)
- Oregon Health & Science University(US)
- Broad Institute(US)
- Center for Cancer Research(US)